chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chest pain, Demyelinating polyneuropathy, Diarrhoea, Dizziness, Dyslipidaemia
Clinical narrative: Guillain Barre syndrome; Syncopal episode; Acute inflammatory demyelinating polyneuropathy (AIDP); GASTROPARESIS; Insomnia; Poor short-term memory; Spinal stenosis in cervical region; polyneuropathy; Numbness; weakness; Chest pain; Lower extremity pain/bilateral leg pain; Malignant tumor of breast; Lightheadedness; Muscle weakness; Fatigue; This case was reported by a lawyer and described the occurrence of demyelinating polyneuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, an unknown time after receiving Shingrix, the patient experienced demyelinating polyneuropathy (serious criteria GSK medically significant) and guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the demyelinating polyneuropathy and guillain barre syndrome were unknown.   It was unknown if the reporter considered the demyelinating polyneuropathy and guillain barre syndrome to be related to Shingrix.  The initial information received on 10 December 2020, via medical records. As per records, she was alcohol user for 2 to 4 times a month. As per records, she had history of orthostatic hypotension, gastroparesis, retention of urine, unspecified. As per records, he had concurrent 28 April 2019, of spinal stenosis in cervical region, Microscopic colitis, Essential hypertension, dyslipidemia and hypothyroidism. As per records, the female patient received shingles vaccine in 2012. As per records, on 12 September 2019, she had Shingrix (PF) 0.5 ml intramuscular suspension. On 25 November 2019, she had Cobalamin deficiency, muscle weakness, lightheadedness, fatigue, acute inflammatory demyelinating polyneuropathy, In October 2019, she was hospitalized. On 06 January 2020, she was hospitalized for Guillen Barre and chronic diarrhea. On 07 January 2019, breast cancer screening. As per records dated 30 April 2020, she had malignant neoplasm of nipple and areola, left female breast. She also had dyslipidemia, acute inflammatory demyelinating polyneuropathy, cobalamin deficiency. As per records dated 13 February 2020, she had adult hypothyroidism, bilateral renal artery stenosis, Chest pain, chronic pain of lower extremity, dyspnea on exertion, lipedemia, lower extremity pain, syncope, Guilliain-barre syndrome onset date 21 November 2019. As per records, she had gotten the shingles vaccination in September 2019, and developed symptoms of bilateral leg pain and then had a syncopal episode. She was then admitted to the hospital. As per records dated 21 September 2020, she had Guillain-Barre syndrome a year ago. She was hospitalized and in rehab for an extensive amount of time. It thought that might have occurred after her shingles vaccine.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Dyspnoea exertional, Fatigue, Guillain-Barre syndrome, Hypothyroidism, Lipoedema
Clinical narrative: Guillain Barre syndrome; Syncopal episode; Acute inflammatory demyelinating polyneuropathy (AIDP); GASTROPARESIS; Insomnia; Poor short-term memory; Spinal stenosis in cervical region; polyneuropathy; Numbness; weakness; Chest pain; Lower extremity pain/bilateral leg pain; Malignant tumor of breast; Lightheadedness; Muscle weakness; Fatigue; This case was reported by a lawyer and described the occurrence of demyelinating polyneuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, an unknown time after receiving Shingrix, the patient experienced demyelinating polyneuropathy (serious criteria GSK medically significant) and guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the demyelinating polyneuropathy and guillain barre syndrome were unknown.   It was unknown if the reporter considered the demyelinating polyneuropathy and guillain barre syndrome to be related to Shingrix.  The initial information received on 10 December 2020, via medical records. As per records, she was alcohol user for 2 to 4 times a month. As per records, she had history of orthostatic hypotension, gastroparesis, retention of urine, unspecified. As per records, he had concurrent 28 April 2019, of spinal stenosis in cervical region, Microscopic colitis, Essential hypertension, dyslipidemia and hypothyroidism. As per records, the female patient received shingles vaccine in 2012. As per records, on 12 September 2019, she had Shingrix (PF) 0.5 ml intramuscular suspension. On 25 November 2019, she had Cobalamin deficiency, muscle weakness, lightheadedness, fatigue, acute inflammatory demyelinating polyneuropathy, In October 2019, she was hospitalized. On 06 January 2020, she was hospitalized for Guillen Barre and chronic diarrhea. On 07 January 2019, breast cancer screening. As per records dated 30 April 2020, she had malignant neoplasm of nipple and areola, left female breast. She also had dyslipidemia, acute inflammatory demyelinating polyneuropathy, cobalamin deficiency. As per records dated 13 February 2020, she had adult hypothyroidism, bilateral renal artery stenosis, Chest pain, chronic pain of lower extremity, dyspnea on exertion, lipedemia, lower extremity pain, syncope, Guilliain-barre syndrome onset date 21 November 2019. As per records, she had gotten the shingles vaccination in September 2019, and developed symptoms of bilateral leg pain and then had a syncopal episode. She was then admitted to the hospital. As per records dated 21 September 2020, she had Guillain-Barre syndrome a year ago. She was hospitalized and in rehab for an extensive amount of time. It thought that might have occurred after her shingles vaccine.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Malignant nipple neoplasm female, Muscular weakness, Pain, Pain in extremity, Renal artery stenosis
Clinical narrative: Guillain Barre syndrome; Syncopal episode; Acute inflammatory demyelinating polyneuropathy (AIDP); GASTROPARESIS; Insomnia; Poor short-term memory; Spinal stenosis in cervical region; polyneuropathy; Numbness; weakness; Chest pain; Lower extremity pain/bilateral leg pain; Malignant tumor of breast; Lightheadedness; Muscle weakness; Fatigue; This case was reported by a lawyer and described the occurrence of demyelinating polyneuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, an unknown time after receiving Shingrix, the patient experienced demyelinating polyneuropathy (serious criteria GSK medically significant) and guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the demyelinating polyneuropathy and guillain barre syndrome were unknown.   It was unknown if the reporter considered the demyelinating polyneuropathy and guillain barre syndrome to be related to Shingrix.  The initial information received on 10 December 2020, via medical records. As per records, she was alcohol user for 2 to 4 times a month. As per records, she had history of orthostatic hypotension, gastroparesis, retention of urine, unspecified. As per records, he had concurrent 28 April 2019, of spinal stenosis in cervical region, Microscopic colitis, Essential hypertension, dyslipidemia and hypothyroidism. As per records, the female patient received shingles vaccine in 2012. As per records, on 12 September 2019, she had Shingrix (PF) 0.5 ml intramuscular suspension. On 25 November 2019, she had Cobalamin deficiency, muscle weakness, lightheadedness, fatigue, acute inflammatory demyelinating polyneuropathy, In October 2019, she was hospitalized. On 06 January 2020, she was hospitalized for Guillen Barre and chronic diarrhea. On 07 January 2019, breast cancer screening. As per records dated 30 April 2020, she had malignant neoplasm of nipple and areola, left female breast. She also had dyslipidemia, acute inflammatory demyelinating polyneuropathy, cobalamin deficiency. As per records dated 13 February 2020, she had adult hypothyroidism, bilateral renal artery stenosis, Chest pain, chronic pain of lower extremity, dyspnea on exertion, lipedemia, lower extremity pain, syncope, Guilliain-barre syndrome onset date 21 November 2019. As per records, she had gotten the shingles vaccination in September 2019, and developed symptoms of bilateral leg pain and then had a syncopal episode. She was then admitted to the hospital. As per records dated 21 September 2020, she had Guillain-Barre syndrome a year ago. She was hospitalized and in rehab for an extensive amount of time. It thought that might have occurred after her shingles vaccine.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Syncope, Vitamin B12 deficiency
Clinical narrative: Guillain Barre syndrome; Syncopal episode; Acute inflammatory demyelinating polyneuropathy (AIDP); GASTROPARESIS; Insomnia; Poor short-term memory; Spinal stenosis in cervical region; polyneuropathy; Numbness; weakness; Chest pain; Lower extremity pain/bilateral leg pain; Malignant tumor of breast; Lightheadedness; Muscle weakness; Fatigue; This case was reported by a lawyer and described the occurrence of demyelinating polyneuropathy in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, an unknown time after receiving Shingrix, the patient experienced demyelinating polyneuropathy (serious criteria GSK medically significant) and guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the demyelinating polyneuropathy and guillain barre syndrome were unknown.   It was unknown if the reporter considered the demyelinating polyneuropathy and guillain barre syndrome to be related to Shingrix.  The initial information received on 10 December 2020, via medical records. As per records, she was alcohol user for 2 to 4 times a month. As per records, she had history of orthostatic hypotension, gastroparesis, retention of urine, unspecified. As per records, he had concurrent 28 April 2019, of spinal stenosis in cervical region, Microscopic colitis, Essential hypertension, dyslipidemia and hypothyroidism. As per records, the female patient received shingles vaccine in 2012. As per records, on 12 September 2019, she had Shingrix (PF) 0.5 ml intramuscular suspension. On 25 November 2019, she had Cobalamin deficiency, muscle weakness, lightheadedness, fatigue, acute inflammatory demyelinating polyneuropathy, In October 2019, she was hospitalized. On 06 January 2020, she was hospitalized for Guillen Barre and chronic diarrhea. On 07 January 2019, breast cancer screening. As per records dated 30 April 2020, she had malignant neoplasm of nipple and areola, left female breast. She also had dyslipidemia, acute inflammatory demyelinating polyneuropathy, cobalamin deficiency. As per records dated 13 February 2020, she had adult hypothyroidism, bilateral renal artery stenosis, Chest pain, chronic pain of lower extremity, dyspnea on exertion, lipedemia, lower extremity pain, syncope, Guilliain-barre syndrome onset date 21 November 2019. As per records, she had gotten the shingles vaccination in September 2019, and developed symptoms of bilateral leg pain and then had a syncopal episode. She was then admitted to the hospital. As per records dated 21 September 2020, she had Guillain-Barre syndrome a year ago. She was hospitalized and in rehab for an extensive amount of time. It thought that might have occurred after her shingles vaccine.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site scab
Clinical narrative: scab formed over the injection site bruising; injection site had bruising; may have hit a blood vessel; This case was reported by a pharmacist via call center representative and described the occurrence of injection site scab in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 2ZN2D, expiry date 16th September 2022) for prophylaxis.   On 17th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 17th October 2020, unknown after receiving Shingrix, the patient experienced wrong injection technique. On 19th October 2020, the patient experienced injection site bruising. On 24th October 2020, the patient experienced injection site scab. On an unknown date, the outcome of the injection site scab and injection site bruising were recovered/resolved and the outcome of the wrong injection technique was unknown.   It was unknown if the reporter considered the injection site scab and injection site bruising to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix in the left arm. The pharmacist reports that upon injection, she might have hit a blood vessel.  Injection site had bruising 2 days after the injection, which appeared about 2 days post injection.  A scab formed over the injection site bruising at about 7 days post injection, and that had resolved.  The reporter consented to follow up.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased
Clinical narrative: Increased liver enzymes (ALT and AST); Increased liver enzymes (ALT and AST); This case was reported by a consumer via call center representative and described the occurrence of alanine aminotransferase increased in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 3rd December 2020, 100 days after receiving Shingrix, the patient experienced alanine aminotransferase increased and aspartate aminotransferase increased. On an unknown date, the outcome of the alanine aminotransferase increased and aspartate aminotransferase increased were unknown.   It was unknown if the reporter considered the alanine aminotransferase increased and aspartate aminotransferase increased to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Patient did not have lot number or expiration date information to provide. The patient received the dose of Shingrix vaccine.  The patient reported increased liver enzymes (ALT and AST) that was reported to her by her doctor. The reporter did not consent to follow up.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Incomplete course of vaccination, Injection site erythema, Injection site warmth, Pain in extremity
Clinical narrative: Injection site reactions in her left arm.  The area was red; Injection site reactions in her left arm / Hot to touch; Arm was sore; 1st dose 1/15/2020 and has not received the 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis.   On 15th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, pain in arm and incomplete course of vaccination. On an unknown date, the outcome of the injection site erythema, injection site warmth and pain in arm were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth and pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced injection site reactions in her left arm.   The area was red, hot to touch and the arm was sore for several days. Till the tme of reporting, the patient did not receive 2nd dose, which led incomplete course of vaccination. This case has been linked with case US2020244407, reported by same reporter. The reporter did not consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020244407:same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site warmth, Pain in extremity
Clinical narrative: Injection site reactions.  The area was red; Injection site reactions / Hot to touch; Arm was sore; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema, injection site warmth and pain in arm. On an unknown date, the outcome of the injection site erythema, injection site warmth and pain in arm were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth and pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received her 1st dose sometime last year (in 2019). She experienced injection site reactions. The area was red, hot to touch and the arm was sore for several days.  She received her 2nd dose and did not experience any reactions. The reporter did not consent to follow-up. This case has been linked with case US2020244406, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020244406:same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Injection site erythema
Clinical narrative: redness at injection site; chills; tiredness for 3 to 4 days; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site erythema, fatigue and chills. On an unknown date, the outcome of the injection site erythema and chills were unknown and the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the injection site erythema, fatigue and chills to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced tiredness for 3 to 4 days. The reporter did not consent to follow-up.
Sex: M
Vaccine: HEP, HEP
Symptoms: Blood cholesterol increased, Diabetes mellitus, Incomplete course of vaccination, Thyroid disorder
Clinical narrative: patient has Diabetes; High Cholesterol; Thyroid problems; received 1st dose of Engerix B in 2010 and did not complete the series yet; This case was reported by a pharmacist via call center representative and described the occurrence of diabetes in a adult male patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received the 1st dose of Engerix B and the 2nd dose of Engerix B. On an unknown date, more than 2 years after receiving Engerix B and not applicable after receiving Engerix B, the patient experienced diabetes (serious criteria GSK medically significant), blood cholesterol increased, thyroid disorder and incomplete course of vaccination. On an unknown date, the outcome of the diabetes, blood cholesterol increased, thyroid disorder and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the diabetes, blood cholesterol increased and thyroid disorder to be related to Engerix B.  Additional details were reported as follows: The age at vaccination was not reported. The patient received the 1st dose of Engerix B in 2010.  The reporter stated that the patient had diabetes, thyroid problems and high cholesterol but was not aware if these conditions were prior to dose 1 of Engerix B. The reporter consented to follow up. All patient identifiers were reported, no batch number or expiration date reported when asked.  The patient received the 1st dose in 2020 and did not complete the series till the time of reporting which led to incomplete course of vaccination. The reporter asked should they have to revaccinate or administering 2nd and 3rd dose would be ok.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Gait inability, Injection site pain, Joint swelling, Loss of consciousness
Clinical narrative: Pain is so bad / had an episode of passing out; Severe pain behind her right knee; Severe pain / left bicep; Unable to walk without a walker; Swelling behind her right knee; This case was reported by a consumer via call center representative and described the occurrence of passed out in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th November 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In November 2020, less than a week after receiving Shingrix, the patient experienced passed out (serious criteria hospitalization and GSK medically significant), knee pain (serious criteria hospitalization), muscle pain (serious criteria hospitalization), unable to walk (serious criteria hospitalization) and swelling of knees (serious criteria hospitalization). On 4th January 2021, the outcome of the knee pain, muscle pain and unable to walk were recovered/resolved. On an unknown date, the outcome of the passed out was recovered/resolved and the outcome of the swelling of knees was unknown.   It was unknown if the reporter considered the passed out, knee pain, muscle pain, unable to walk and swelling of knees to be related to Shingrix.  Additional details were reported as follows: The case is reported by husband of patient. He stated that his wife received the second dose of Shingrix and about 3 to 4 days later, she began to experience severe pain behind her right knee and left bicep. She also had swelling behind her right knee. The pain was so bad, she had an episode of passing out. She went to the emergency room and was kept overnight for observation and then discharged.  She was unable to walk without a walker. Provided medical disclaimer and advised to follow up with his wife's health care professional.  The reporter did not consent to follow-up. Note: Reaction end date is given for pain and swelling behind right knee and pain in left bicep but outcome given as not recovered. Captured outcome as recovered as reaction end date is given.  Discrepant information reported in XML and narrative for onset date of events. Events onset date captured as per narrative.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Walking aid user
Clinical narrative: Pain is so bad / had an episode of passing out; Severe pain behind her right knee; Severe pain / left bicep; Unable to walk without a walker; Swelling behind her right knee; This case was reported by a consumer via call center representative and described the occurrence of passed out in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th November 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In November 2020, less than a week after receiving Shingrix, the patient experienced passed out (serious criteria hospitalization and GSK medically significant), knee pain (serious criteria hospitalization), muscle pain (serious criteria hospitalization), unable to walk (serious criteria hospitalization) and swelling of knees (serious criteria hospitalization). On 4th January 2021, the outcome of the knee pain, muscle pain and unable to walk were recovered/resolved. On an unknown date, the outcome of the passed out was recovered/resolved and the outcome of the swelling of knees was unknown.   It was unknown if the reporter considered the passed out, knee pain, muscle pain, unable to walk and swelling of knees to be related to Shingrix.  Additional details were reported as follows: The case is reported by husband of patient. He stated that his wife received the second dose of Shingrix and about 3 to 4 days later, she began to experience severe pain behind her right knee and left bicep. She also had swelling behind her right knee. The pain was so bad, she had an episode of passing out. She went to the emergency room and was kept overnight for observation and then discharged.  She was unable to walk without a walker. Provided medical disclaimer and advised to follow up with his wife's health care professional.  The reporter did not consent to follow-up. Note: Reaction end date is given for pain and swelling behind right knee and pain in left bicep but outcome given as not recovered. Captured outcome as recovered as reaction end date is given.  Discrepant information reported in XML and narrative for onset date of events. Events onset date captured as per narrative.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Mass, Pain, Swelling
Clinical narrative: Redness around injection site the day after. Swelling like a lump or knot under skin and pain increase second day. Third day itchy skin at injection site but less pain.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: Received a COVID-19 vaccination in his left arm and 9:15 on 12/182020 and states that he felt some swelling sensation in his throat.  He received 25 mg of Benadryl there initially and then a few minutes later got another 25.  He had no chest pain or shortness of breath.  He had no difficulty swallowing.  He has had somewhat of a similar reaction in the past when he is exposed to cat hair.  He was sent to ED by EMS for further evaluation.   No rash.  Arrived 10:16am, given pepcid, declined steroids and discharged at 11:47am.  Felt normal within 2-3 hrs after receiving the vaccine.  Given EpiPen for second dose.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache
Clinical narrative: Shoulder, Trapezius pain..severe.  Severe headache.  All occurring days afterwards
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Neck pain, Pain, Pain in extremity
Clinical narrative: -on 1/6/21 my right arm started feeling sore -on 1/7/21 when I woke up in the morning I was very cold for four hours. My feet remained cold the entire day. I also woke up with a headache which lasted all day. In the late afternoon my body started aching which lasted all night. On my right arm well below the injection site my skin pigmentation changed; there is a patch of skin which is now lighter. -on 1/8/21 my head still hurts, my neck area feels very sore. I still have the skin color change on my arm
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Skin discolouration
Clinical narrative: -on 1/6/21 my right arm started feeling sore -on 1/7/21 when I woke up in the morning I was very cold for four hours. My feet remained cold the entire day. I also woke up with a headache which lasted all day. In the late afternoon my body started aching which lasted all night. On my right arm well below the injection site my skin pigmentation changed; there is a patch of skin which is now lighter. -on 1/8/21 my head still hurts, my neck area feels very sore. I still have the skin color change on my arm
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Confusional state, Dissociative amnesia, Dizziness, Electrocardiogram, Feeling hot
Clinical narrative: Approximately 1 hour after receiving dose #1 of Moderna COVID vaccine, I was sitting at work desk and suddenly felt flushed/hot throughout body; told nearby co-workers I felt light-headed; nearby co-workers then noticed I became quiet, sat and stared into space for about a 30 second timespan while sitting at desk; Co-workers then noticed I was confused and seemed to lose a span of time; Co-workers assisted me to lay down and made suggestion to go to ED. I refused to go to ED and continued to be confused for about 15 mins. Patient returned to baseline state and did not recall the events; I then agreed to go to ED; Co-workers wheeled me to ED where an EKG was done and released after an hour of observation.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Flushing, Social avoidant behaviour, Staring
Clinical narrative: Approximately 1 hour after receiving dose #1 of Moderna COVID vaccine, I was sitting at work desk and suddenly felt flushed/hot throughout body; told nearby co-workers I felt light-headed; nearby co-workers then noticed I became quiet, sat and stared into space for about a 30 second timespan while sitting at desk; Co-workers then noticed I was confused and seemed to lose a span of time; Co-workers assisted me to lay down and made suggestion to go to ED. I refused to go to ED and continued to be confused for about 15 mins. Patient returned to baseline state and did not recall the events; I then agreed to go to ED; Co-workers wheeled me to ED where an EKG was done and released after an hour of observation.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: DIZZINESS
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Urticaria
Clinical narrative: Started with hives approximately 15 minutes after and then went into full Anaphylaxis. Required epi and Benadryl.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Pyrexia
Clinical narrative: Fever, chills, flu like symptoms
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Nausea, Retching
Clinical narrative: Nausea and dry heave, diarrhea once, epigastric pain. 18 hours post injection. Treated with Maalox 60 ml single dose. Symptoms resolved.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Pain, Painful respiration
Clinical narrative: 1. Pulsing pain at dose administration site at 11 pm.  -No treatment, went to sleep. 2. (12 hrs after administration).  Woke up at 1:00 am with severe chills.  Lasted 2 hours.  -Threw on sweats and another blanket, went back to sleep. 3. Woke up at 6:30 am with intense body and head pain.  "was a cant get comfortable in any position type of pulsing pain" Something im accustomed to when i get the Flu.  I rolled around in pain for 4 hours while trying to go back to sleep; it even hurt to breathe deeply. - took Tylenol at 11am and the symptoms never came back.  *Note.  I think i suffered so much pain in the 4 hours that it lasted with me until even now as i write this.  Hard to describe, but my entire body has had this tiny ache that has not gone away.  Not a big deal to me, but just wanted it documented.  I am selecting recovered even with that tiny ache still apparent because physical pain usually takes time to heal.  Assuming that's all it is.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Feeling hot
Clinical narrative: Injection given in Left Deltoid. No complaints at this time of injection.  Arrived in waiting area at 0725.  At 0750 C/o feeling warm, skin clammy, alert and oriented x 3.  Felt like a hot flash. BP 141/75, P=74.     At 0754A states feeling much better, skin warm, dry.  BP 139/69, P=67  At 0757 Patient chatting, alert and oriented x 3, skin warm, dry BP 169/93, P = 76. patient left observation room with husband who drove her home
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Computerised tomogram abnormal, Eye swelling, Intensive care, Laboratory test
Clinical narrative: Anaphylactic reaction,  Severe edema and raised red rash entire body, Severe itching ,Soft tissue edema of throat. Swelling of, eyes, lips, face. Multiple trips to ER, treated with steroids, Benadryl, prevacid. , CURRENTLY IN ICU ON EPINEPHRINE DRIP, STEROIDS, MULTIPLE MEDS
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Oedema, Pharyngeal oedema, Pruritus, Rash
Clinical narrative: Anaphylactic reaction,  Severe edema and raised red rash entire body, Severe itching ,Soft tissue edema of throat. Swelling of, eyes, lips, face. Multiple trips to ER, treated with steroids, Benadryl, prevacid. , CURRENTLY IN ICU ON EPINEPHRINE DRIP, STEROIDS, MULTIPLE MEDS
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash papular, Swelling face
Clinical narrative: Anaphylactic reaction,  Severe edema and raised red rash entire body, Severe itching ,Soft tissue edema of throat. Swelling of, eyes, lips, face. Multiple trips to ER, treated with steroids, Benadryl, prevacid. , CURRENTLY IN ICU ON EPINEPHRINE DRIP, STEROIDS, MULTIPLE MEDS
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site cellulitis, Injection site rash, Injection site swelling, Injection site warmth, Rash pruritic
Clinical narrative: Hot , raised, itchy rash below injection site on Left Arm resembling cellulitis
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Fatigue, Headache, Musculoskeletal discomfort, Pain
Clinical narrative: I had pretty severe symptoms about 12 hours after the vaccine. I received the vaccine on 1/6 at 8 am. Serve headache, body aches, chill, fever. They lasted about 12 hours and then most of today just overall fatigue. I now have discomfort in my back and chest. Is this normal?
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: I had pretty severe symptoms about 12 hours after the vaccine. I received the vaccine on 1/6 at 8 am. Serve headache, body aches, chill, fever. They lasted about 12 hours and then most of today just overall fatigue. I now have discomfort in my back and chest. Is this normal?
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Upon leaving observation, pt stated her lips felt "tingly".  No edema present to site.  Pt, recieved (2) Benadryl 25mg from this nurse to take w/ her.  Pt was currently @ work, and did not want to take meds @ present time.  Left observation @ 11.02.
Age: 47.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Induration, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Arm  swelling,, baseball sized knot. fever, chills, nausea
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Developed facial swelling.  Diphenydramine administered.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Poor quality sleep
Clinical narrative: Symptoms - ? EE reports beginning at approximately 19:00 (1/7) chills and myalgias.  EE reports she tossed and turned last night so woke up feeling pretty tired.  EE reports today she feels okay minus feeling a bit tired.  EE denies fever, COVID-19 exposure without proper PPE and recent travel.   Last day of work and shift - ? unknown Home remedies? -   none Any improvement? - yes Recommendation? EE encouraged to continue to monitor her symptoms and to call vaccine support line with further questions/concerns.  EE verbalized back understanding and denied further questions at this time.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Myalgia, Nausea
Clinical narrative: Within an hour, I started having a headache and feeling a little "prodromal".  Within 12 hours, I started having severe diffuse muscle aches.   The next 17-29 hours, I continued with severe diffuse muscle aches, headache, nausea, and chills.  Symptoms subsided after 29 hours.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site reaction, Keloid scar
Clinical narrative: It has been over a week.  Early this week 1/5 I noticed continued mild pain, itching, redness and a keloid on left arm at site of injection.  Very uncomfortable, especiall itchiness.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Mobility decreased, Pain in extremity, Paraesthesia, Pyrexia
Clinical narrative: On day 2 evening the 5th I developed severe arm soreness. Could not lift or put pressure on it. That evening I developed fever that lasted a full day. On the 8th I have numbness and tingling on the same left arm.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: On day 2 evening the 5th I developed severe arm soreness. Could not lift or put pressure on it. That evening I developed fever that lasted a full day. On the 8th I have numbness and tingling on the same left arm.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bone pain, Chills, Dysphagia, Face oedema
Clinical narrative: 1/8: 10:00- began to develop increased soreness and fatigue 14:00 began to develop fever, chills, headache, nausea l, muscle soreness, bone pain, fatigue onset and are consistently present.. Required to leave early secondary to symptoms. Tylenol administered 20:00  lip and facial edema noted to onset. Nausea and dry heaving onsets, feeling of malaise. Fever of 102.3. tylenol given 23:30 lip edema worsening. Pain worsening. Weakness onsets . Continued fever of 101.3. 50 mg of benadryl and pepcid administered 1/9 4:00 bone pain and chills improced. Continued fatigue, muscle aches, headache and nausea. lip edema not improved. Mild facial edema noted. Increased difficulty swallowing noted and dry heaving continues. Care sought in ED. IV decadron and benadryl administered  6:30 discharged from ED with zyrtec, prednisone taper and pepcid scripts. Countinued home monitoring 11:00 lip edema stable. Fever improved. Fatigue, soreness, headache continue to be present, but improved
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Impaired work ability, Malaise, Myalgia
Clinical narrative: 1/8: 10:00- began to develop increased soreness and fatigue 14:00 began to develop fever, chills, headache, nausea l, muscle soreness, bone pain, fatigue onset and are consistently present.. Required to leave early secondary to symptoms. Tylenol administered 20:00  lip and facial edema noted to onset. Nausea and dry heaving onsets, feeling of malaise. Fever of 102.3. tylenol given 23:30 lip edema worsening. Pain worsening. Weakness onsets . Continued fever of 101.3. 50 mg of benadryl and pepcid administered 1/9 4:00 bone pain and chills improced. Continued fatigue, muscle aches, headache and nausea. lip edema not improved. Mild facial edema noted. Increased difficulty swallowing noted and dry heaving continues. Care sought in ED. IV decadron and benadryl administered  6:30 discharged from ED with zyrtec, prednisone taper and pepcid scripts. Countinued home monitoring 11:00 lip edema stable. Fever improved. Fatigue, soreness, headache continue to be present, but improved
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Retching
Clinical narrative: 1/8: 10:00- began to develop increased soreness and fatigue 14:00 began to develop fever, chills, headache, nausea l, muscle soreness, bone pain, fatigue onset and are consistently present.. Required to leave early secondary to symptoms. Tylenol administered 20:00  lip and facial edema noted to onset. Nausea and dry heaving onsets, feeling of malaise. Fever of 102.3. tylenol given 23:30 lip edema worsening. Pain worsening. Weakness onsets . Continued fever of 101.3. 50 mg of benadryl and pepcid administered 1/9 4:00 bone pain and chills improced. Continued fatigue, muscle aches, headache and nausea. lip edema not improved. Mild facial edema noted. Increased difficulty swallowing noted and dry heaving continues. Care sought in ED. IV decadron and benadryl administered  6:30 discharged from ED with zyrtec, prednisone taper and pepcid scripts. Countinued home monitoring 11:00 lip edema stable. Fever improved. Fatigue, soreness, headache continue to be present, but improved
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Moderna COVID-19 Vaccine EUA 7 days after the first injection of the Moderna vaccine, the area of my left shoulder where the vaccine was given became red, mildly sore, raised and warm.  It was an area about 4 inches long and 2 inches wide. I also experienced some discomfort in my left underarm at the same time.  My arm was sore, but not as sore as it was in the initial 24 hours after receiving the vaccine.  I did not have a fever.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Rhinorrhoea, Throat irritation
Clinical narrative: Have had sniffles and a scratchy throat with dry cough. Symptoms usually associated with a cold. Unsure if related to vaccine, but haven't been around anyone sick.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Dizziness, Ear pain, Headache, Hypoaesthesia
Clinical narrative: Tingling and numb face and lips mostly on right side of face, right ear pain, right jaw pain, right side headache, sore arm at site, nausea, dizziness, lethargic
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Injection site pain, Lethargy, Nausea, Pain in jaw
Clinical narrative: Tingling and numb face and lips mostly on right side of face, right ear pain, right jaw pain, right side headache, sore arm at site, nausea, dizziness, lethargic
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling and numb face and lips mostly on right side of face, right ear pain, right jaw pain, right side headache, sore arm at site, nausea, dizziness, lethargic
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Decreased appetite, Diarrhoea, Dizziness
Clinical narrative: Around at 7AM when I arrived at work I started feeling chills, took temperature 99.5F that is already elevated for me.  About 9:30 my temp was 101.8F and they sent me home.  I just had the chills and fever.  I got home and developed a headache and around 1PM I started feeling really dizzy. The temperature did not subside and the next day I woke up and I couldn't function, I felt really dizzy I kept laying down and drinking water, I could not keep anything down my stomach did not feel well. I felt like I had to vomit. When I sat down in the toilet then my ears started ringing pretty bad all of a sudden I could not hear anything and I passed out in the toilet. My husband found me and tried to wake me up. After that I still feel dizzy. I did not have any appetite either. I could barely hold water. The next day I was not as dizzy but my stomach was still upset but I could hold some soup down but then started with diarrhea. Employee health kept calling me everyday and I did the the telehealth appt and I also had a little bit of a rash in my chest that appeared all of a sudden red like a streak. The dizziness I had for the first 4 days, diarrhea did not come until the 3rd day and I had it for 2 days and my temperature was back to normal on the 4th day. Everything started to get better (my stomach stopped feeling queezy) around the 4th day but still felt fatigued until about 12/29/2020.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Headache, Loss of consciousness, Malaise
Clinical narrative: Around at 7AM when I arrived at work I started feeling chills, took temperature 99.5F that is already elevated for me.  About 9:30 my temp was 101.8F and they sent me home.  I just had the chills and fever.  I got home and developed a headache and around 1PM I started feeling really dizzy. The temperature did not subside and the next day I woke up and I couldn't function, I felt really dizzy I kept laying down and drinking water, I could not keep anything down my stomach did not feel well. I felt like I had to vomit. When I sat down in the toilet then my ears started ringing pretty bad all of a sudden I could not hear anything and I passed out in the toilet. My husband found me and tried to wake me up. After that I still feel dizzy. I did not have any appetite either. I could barely hold water. The next day I was not as dizzy but my stomach was still upset but I could hold some soup down but then started with diarrhea. Employee health kept calling me everyday and I did the the telehealth appt and I also had a little bit of a rash in my chest that appeared all of a sudden red like a streak. The dizziness I had for the first 4 days, diarrhea did not come until the 3rd day and I had it for 2 days and my temperature was back to normal on the 4th day. Everything started to get better (my stomach stopped feeling queezy) around the 4th day but still felt fatigued until about 12/29/2020.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, SARS-CoV-2 test negative, Tinnitus, Vomiting
Clinical narrative: Around at 7AM when I arrived at work I started feeling chills, took temperature 99.5F that is already elevated for me.  About 9:30 my temp was 101.8F and they sent me home.  I just had the chills and fever.  I got home and developed a headache and around 1PM I started feeling really dizzy. The temperature did not subside and the next day I woke up and I couldn't function, I felt really dizzy I kept laying down and drinking water, I could not keep anything down my stomach did not feel well. I felt like I had to vomit. When I sat down in the toilet then my ears started ringing pretty bad all of a sudden I could not hear anything and I passed out in the toilet. My husband found me and tried to wake me up. After that I still feel dizzy. I did not have any appetite either. I could barely hold water. The next day I was not as dizzy but my stomach was still upset but I could hold some soup down but then started with diarrhea. Employee health kept calling me everyday and I did the the telehealth appt and I also had a little bit of a rash in my chest that appeared all of a sudden red like a streak. The dizziness I had for the first 4 days, diarrhea did not come until the 3rd day and I had it for 2 days and my temperature was back to normal on the 4th day. Everything started to get better (my stomach stopped feeling queezy) around the 4th day but still felt fatigued until about 12/29/2020.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Injection site warmth, Pain
Clinical narrative: Patient stated his arm from his elbow to his shoulder was warm for 1 hour. He also stated he was achy and he had joint aches more then usual.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Chills, Cough, Diarrhoea, Dyspnoea
Clinical narrative: very fatigue and sore arm, headache,  the night of the shot. 01/06/2021, Very fatigue, chills, fever, body aches, red spot where shot was given, slight headache,  01/07/2021 cough, sob, asthma like symptoms, headache, body aches, slight fever. 99.9, loose stools,   01/08/2021
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Pain, Pain in extremity
Clinical narrative: very fatigue and sore arm, headache,  the night of the shot. 01/06/2021, Very fatigue, chills, fever, body aches, red spot where shot was given, slight headache,  01/07/2021 cough, sob, asthma like symptoms, headache, body aches, slight fever. 99.9, loose stools,   01/08/2021
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: very fatigue and sore arm, headache,  the night of the shot. 01/06/2021, Very fatigue, chills, fever, body aches, red spot where shot was given, slight headache,  01/07/2021 cough, sob, asthma like symptoms, headache, body aches, slight fever. 99.9, loose stools,   01/08/2021
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Skin warm
Clinical narrative: Warm, swollen, erythematous spreading rash
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Dizziness, Headache, Hyperhidrosis, Nausea
Clinical narrative: patient reports fasting high blood sugar >200 12+ hours after vaccination - she is diabetic on oral metformin and has never had elevated blood sugar >140 with fasting; controlled HgA1C at 6.1%; felt dizzy, nauseated, HA and sweaty as if she may pass out - never passed out
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: Left Eye Swelling
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Paraesthesia oral, Pharyngeal paraesthesia, Throat tightness
Clinical narrative: 5 minutes after injection had internal thickening of throat and difficulty swallowing. After a couple of minutes swallowing improved but throat thickening continued for another approximately 15 minutes. At 50 minutes after the injection had faint tingling around the mouth and mild throat internal throat thickening again. Took 25 mg of Benadryl. No further s/s.